Status:
COMPLETED
Hsv 1 and 2 Gowey Protocol Versus Placebo
Lead Sponsor:
Naturopaths International
Conditions:
Herpes
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.
Detailed Description
Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies...
Eligibility Criteria
Inclusion
- \- Hsv 1\&2
Exclusion
- No active lesions
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01477879
Start Date
January 1 2011
End Date
March 1 2011
Last Update
November 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naturopaths international
Flagstaff, Arizona, United States, 86001